7Baggers
 BMRN Maintained by RBC Capital -- Price Target Lowered to $62  GuruFocus Tue, 07 Jul 2026 16:48:30 GMT
 The Future of Biotech? BridgeBio, Ionis and BioMarin Are Worth Watching  Technology Org Tue, 07 Jul 2026 06:16:46 GMT
 BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook Reveals 48.92% Potential Upside  DirectorsTalk Interviews Mon, 06 Jul 2026 09:21:48 GMT
 BMRN - Biomarin Pharmaceutical Inc Options  Finviz Sat, 04 Jul 2026 10:09:51 GMT
 bmrn - biomarin pharmaceutical inc options  Finviz Fri, 03 Jul 2026 21:20:54 GMT
 BMRN - Biomarin Pharmaceutical Inc Volatility & Greeks  Finviz Fri, 03 Jul 2026 07:53:28 GMT
 bmrn - biomarin pharmaceutical inc volatility & greeks  Finviz Thu, 02 Jul 2026 17:28:14 GMT
 the future of biotech? bridgebio, ionis and biomarin are worth watching  Technology Org Thu, 02 Jul 2026 06:39:04 GMT
 BioMarin Pharmaceutical Inc.(NasdaqGS: BMRN) added to Russell 2500 Index  marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
 our origin story  BioMarin Pharmaceutical Sat, 27 Jun 2026 17:51:53 GMT
 biomarin pharmaceutical, friday analyst angle, shares in focus  Ad-hoc-news.de Fri, 26 Jun 2026 15:29:56 GMT
 2 healthcare stocks for long-term investors and 1 we brush off  StockStory Fri, 26 Jun 2026 10:02:46 GMT
 BioMarin Pharmaceutical Inc. Actuals & Estimates (NASDAQ:BMRN)  TradingView Thu, 25 Jun 2026 18:48:17 GMT
 bmrn forecast — price target — prediction for 2027  TradingView Thu, 25 Jun 2026 15:03:46 GMT
 How Biomarin Pharmaceutical Inc. (BMRN) Affects Rotational Strategy Timing  Stock Traders Daily Thu, 25 Jun 2026 04:24:01 GMT
 from unexpected turn to purposeful impact | biomarin  BioMarin Pharmaceutical Wed, 24 Jun 2026 16:45:10 GMT
 our origin story  BioMarin Pharmaceutical Tue, 23 Jun 2026 09:23:14 GMT
 biomarin pharmaceutical inc (bmrn) institutional confidence  TradingKey Tue, 23 Jun 2026 07:00:00 GMT
 10 most promising stocks with highest upside potential  Insider Monkey Mon, 22 Jun 2026 20:08:21 GMT
 biomarin pharmaceutical inc. (bmrn) stock analysis: unpacking a 60% upside potential  DirectorsTalk Interviews Mon, 22 Jun 2026 09:26:15 GMT
 biomarin stock maintained at neutral by h.c. wainwright on trial data  Investing.com Mon, 22 Jun 2026 07:00:00 GMT
 stifel reiterates hold on biomarin stock, keeps $68 price target  Investing.com Mon, 22 Jun 2026 07:00:00 GMT
 biomarin pharmaceutical inc (bmrn) institutional confidence  TradingKey Thu, 18 Jun 2026 07:52:42 GMT
 our origin story  BioMarin Pharmaceutical Wed, 17 Jun 2026 20:38:25 GMT
 vosoritide data support planned fda submission for hypochondroplasia  Contemporary Pediatrics Tue, 16 Jun 2026 14:52:36 GMT
 biomarin presents three-year voxzogo data for hypochondroplasia by investing.com  Investing.com Nigeria Tue, 16 Jun 2026 13:25:33 GMT
 (bmrn) and the role of price-sensitive allocations  Stock Traders Daily Sun, 14 Jun 2026 03:12:01 GMT
 social life, support and self-advocacy for teens with pku | biomarin  BioMarin Pharmaceutical Thu, 11 Jun 2026 18:00:54 GMT
 bmrn technical analysis & stock price forecast  Intellectia AI Tue, 09 Jun 2026 04:29:02 GMT
 biomarin pharmaceutical inc. (bmrn) stock analysis: exploring a 54.74% potential upside  DirectorsTalk Interviews Mon, 08 Jun 2026 07:00:00 GMT
 biomarin (bmrn) director receives 7,490 rsus in stock grant  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 director at biomarin (nasdaq: bmrn) awarded 7,490 rsus  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 biomarin (nasdaq: bmrn) director receives 7,490-share rsu grant  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 biomarin (bmrn) director maykin ho receives 7,490 stock units  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 biomarin (bmrn) director gets 7,490 rsus, holds 21,045 shares  Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
 biomarin gains on voxzogo phase 3 results  MSN Thu, 04 Jun 2026 05:11:09 GMT
 BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?  Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
 biomarin pharmaceutical hits day high with 8.63% surge in stock price  Markets Mojo Wed, 03 Jun 2026 05:38:46 GMT
 responsive playbooks and the bmrn inflection  Stock Traders Daily Wed, 03 Jun 2026 01:42:01 GMT
 bmrn - biomarin pharmaceutical inc stock price and quote  Finviz Tue, 26 May 2026 10:51:04 GMT
 the week in pharma: action, reaction and insight – week to may 22, 2026  The Pharma Letter Sun, 24 May 2026 18:19:08 GMT
 why biomarin pharmaceutical (bmrn) stock is trading up today  Yahoo Finance Sat, 23 May 2026 07:00:00 GMT
 understanding the setup: (bmrn) and scalable risk  Stock Traders Daily Sat, 23 May 2026 00:34:01 GMT
 citigroup and i are aligned on these 3 mid-cap biopharma stocks  TheStreet Pro Fri, 22 May 2026 15:35:00 GMT
 h.c. wainwright reiterates neutral on biomarin stock, $50 target  Investing.com Fri, 22 May 2026 12:04:56 GMT
 Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today  Yahoo Finance Fri, 22 May 2026 07:00:00 GMT
 layoff tracker: abbvie, novartis slash us headcount  BioSpace Fri, 22 May 2026 07:00:00 GMT
 why biomarin pharmaceutical (bmrn) stock is trading up today  StockStory Thu, 21 May 2026 20:08:49 GMT
 biomarin looks to expand voxzogo franchise with positive hypochondroplasia data  Citeline News & Insights Thu, 21 May 2026 14:28:06 GMT
 biomarin’s voxzogo hits phase iii goal in hypochondroplasia  The Pharma Letter Thu, 21 May 2026 09:57:41 GMT
 biomarin stock surges on positive hypochondroplasia trial data  Investing.com Wed, 20 May 2026 22:03:31 GMT
 why biomarin’s stock is sinking despite trial win  TipRanks Wed, 20 May 2026 21:38:38 GMT
 biomarin says voxzogo meets phase 3 goal in children with hypochondroplasia  marketscreener.com Wed, 20 May 2026 20:51:49 GMT
 BioMarin’s ENERGY 3 trial of BMN 401 meets one co-primary endpoint  Clinical Trials Arena Wed, 20 May 2026 07:00:00 GMT
 BioMarin moves to expand Voxzogo into hypochondroplasia with pivotal win  FirstWord Pharma Wed, 20 May 2026 07:00:00 GMT
 phase 3 trial shows vosoritide improves growth in children with hypochondroplasia  Contemporary Pediatrics Wed, 20 May 2026 07:00:00 GMT
 ionis, alnylam, biomarin are new buys at citi (alny:nasdaq)  Seeking Alpha Tue, 19 May 2026 18:01:39 GMT
 bmrn stock down on mixed results from rare disease therapy study  Yahoo Finance Tue, 19 May 2026 16:56:00 GMT
 BioMarin drug acquired in buyout misses goal in rare disease study  BioPharma Dive Tue, 19 May 2026 07:00:00 GMT

BioMarin Pharmaceutical Inc
(NASDAQ:BMRN) 

BMRN stock logo

BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment o...

Founded: 1997
Full Time Employees: 3,001
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends